-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Pfizer, Raises Price Target to $30

Benzinga·11/04/2026 23:07:00
Listen to the news
UBS analyst Michael Yee maintains Pfizer (NYSE:PFE) with a Neutral and raises the price target from $27 to $30.